Don't miss important fresh news and information about California's $12 billion stem cell research agency. It is charting a new course with new opportunities and significant changes in direction, including a greater emphasis on the fast-growing gene therapy field.
The changes already mean a lot for patients, researchers and policymakers and will have an even greater impact in the next several years. Tracking the agency's affairs is not easy, but you can find what you need on the The California Stem Cell Report.
Dubbed "indispensable" and "authoritative" in the Los Angeles Times, the Report is the only regular, independent source of news and information dealing with the California Institute for Regenerative Medicine (CIRM).
It is news that can be found nowhere else. Plus it is comprehensive. More than 5,000 items have been published since CIRM was created in 2004.
You can subscribe free to the California Stem Cell Report on its new platform by clicking on the "Subscribe Today!" box on the upper right of this page. Or just go to one of the following recent stories and click on the subscribe button.
California Stem Cell Agency Withholds $5.8 Million from Orchard in Bubble-Baby Flap; Money to Go to New Effort Involving Compassionate Use
